DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE
ActiveSummary
DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.02M and a net result of €206k. Equity is growing by ~13% per year across the filed fiscal years. Its solvency ranks better than 75% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
92
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability90▲+2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €90k at 30 days acceptable
Liquidity ample (current ratio 7.09 against 4.2 in 2024; short-term debt: 6% and cash: 12.6% of total assets), and 15.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
84.1%
Return on assets
17%
Age of the figures
15 mo
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 13-02-2026, 13 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
13 d late
2024
4 d late
2023
1 d early
2022
on the day
2021
15 d late
2020
20 d early
2019
on the day
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close24-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€1.02M▲ 25.3%
2024 · €815k
2019: €433k
2020: €555k
2021: €720k
2022: €873k
2023: €656k
2024: €815k
2019 → 2025
Total assets
€1.21M▲ 16.5%
2024 · €1.04M
2019: €749k
2020: €737k
2021: €1.12M
2022: €1.21M
2023: €1.26M
2024: €1.04M
2019 → 2025
Net result
€206k▲ 29.4%
2024 · €159k
2019: €139k
2020: €122k
2021: €165k
2022: €153k
2023: €118k
2024: €159k
2019 → 2025
Working capital
€447k▲ 63.2%
2024 · €274k
2019: €118k
2020: €215k
2021: €275k
2022: €372k
2023: €139k
2024: €274k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€720k-€873k▲ 21.2%€656k▼ 24.9%€815k▲ 24.3%€1.02M▲ 25.3%
Operating result€235k-€215k▼ 8.5%€157k▼ 26.8%€223k▲ 41.7%€273k▲ 22.2%
Net result€165k-€153k▼ 7.3%€118k▼ 22.9%€159k▲ 35.4%€206k▲ 29.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 22% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.21M
Fixed assets
€693k ▲ 1.6%
Current assets
€520k ▲ 44.8%
Equity and liabilities €1.21M
Equity
€1.02M ▲ 25.3%
Debt
€192k ▼ 15.3%
Debt's share of the balance-sheet total falls from 21.8% to 15.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€294k▲
2024 · €247k
Cash flow
€228k▲
2024 · €184k
Current ratio
7.09▲
2024 · 4.20
Debt to equity
0.19▼
2024 · 0.28
ROE
20.2%▲
2024 · 19.6%
ROA
17.0%▲
2024 · 15.3%
Interest coverage
85.24▲
2024 · 49.21
Debt ≤ 1 year
€73k▼
2024 · €86k
Debt > 1 year
€117k▼
2024 · €140k
Income taxes
€91k▲
2024 · €70k
Staff costs
€20k▼
2024 · €49k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 56 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.04M€1.21M▲
Fixed assets21/28€683k€693k▲
Tangible fixed assets22/27€683k€693k▲
Land and buildings22€682k€663k▼
Plant, machinery and equipment23€421€141▼
Furniture and vehicles24€73€28k▲
Other tangible fixed assets26-€2k
Current assets29/58€359k€520k▲
Amounts receivable within one year40/41€74k€283k▲
Other amounts receivable41€74k€283k▲
Current investments50/53€134k€80k▼
Cash at bank and in hand54/58€145k€152k▲
Deferred charges and accrued income490/1€7k€5k▼
Equity and liabilities
Total equity and liabilities10/49€1.04M€1.21M▲
Equity10/15€815k€1.02M▲
Contributions10/11€12k€12k=
Reserves13€797k€1.00M▲
Non-distributable reserves130/1€0-
Other1319€0-
Distributable reserves133€797k€1.00M▲
Profit (loss) carried forward14€5k€5k▲
Amounts payable17/49€227k€192k▼
Amounts payable after more than one year17€140k€117k▼
Financial debts170/4€140k€117k▼
Amounts payable within one year42/48€86k€73k▼
Current portion of amounts payable after more than one year42€53k€24k▼
Financial debts43€9k€13k▲
Credit institutions430/8€9k€13k▲
Trade debts44€4k€5k▲
Suppliers440/4€4k€5k▲
Taxes, remuneration and social security45€19k€31k▲
Taxes450/3€10k€31k▲
Remuneration and social security454/9€9k€254▼
Other amounts payable47/48€0-
Accrued charges and deferred income492/3€2k€2k▼
Income statement
Code20242025
Non-recurring operating income76A-€4k
Remuneration, social security and pensions62€49k€20k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€24k€21k▼
Other operating charges640/8€5k€5k▲
Gross operating margin9900€301k€319k▲
Operating profit (loss)9901€223k€273k▲
Financial income75/76B€12k€28k▲
Recurring financial income75€12k€28k▲
Financial charges65/66B€5k€3k▼
Recurring financial charges65€5k€3k▼
Profit (loss) for the period before taxes9903€230k€297k▲
Income taxes67/77€70k€91k▲
Profit (loss) for the period9904€159k€206k▲
Profit (loss) for the period to be appropriated9905€159k€206k▲
Appropriation of the result
Profit (loss) to be appropriated9906€165k€212k▲
Profit (loss) brought forward from the previous period14P€5k€5k▲
Transfer from equity791/2€0-
Transfer to equity691/2€159k€206k▲
To other reserves6921€159k€206k▲
Profit to be distributed694/7€0-
Return on contributions (dividend)694€0-
The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 13 days late
2025
30-06
Financial
Highest result since 2019net €206k ▲29.4%
Operating result €273k, net result €206k, both a record.
30-06
Financial
Equity above €1MEq €1.02M ▲25.3%
7 profitable years in a row build equity to €1.02M.
04-02
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 4 days late
2024
30-06
Financial
Liquidity triplescurrent ratio 4.20
Current ratio from 1.33 to 4.20; short-term debt falls from €415k to €86k.
30-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Weakest financial yearnet €118k ▼22.9%
Net result drops to €118k, the lowest in the series; recovery starts the following year.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
15-02
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 15 days late
2021
11-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Liquidity triplescurrent ratio 4.98
Current ratio from 1.75 to 4.98; short-term debt falls from €157k to €54k.
30-06
Financial
Equity above €500kEq €555k ▲28.2%
2 profitable years in a row build equity to €555k.
Show earlier events
31-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
29-01
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
31-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Evergem · 1 establishment unit since 2001
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kluizendorpstraat 399940 EvergemGround area
1,494 m²
Building footprint
191 m²
Volume, LiDAR
1,076 m³
Parcel 43006I0148/02B000, Flanders · tallest building 10.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Kluizendorpstraat 39, 9940 Evergem
since 20012.229.093.058
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 43006I0148/02B000 | Flanders | 1,494 m² | 1 · 191 m² | 10.0 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Stefaan Vandecasteele
BE 0816.993.188
Brugge · Eq €1,021,427
Dr. Veerle Decuypere, cardioloog
BE 0671.990.759
Brugge · Eq €1,021,261
Dr. S.& W. NURADI GYNAECOLOGEN
BE 0477.629.087
Waasmunster · Eq €1,020,936
DOKTER BARBARA BUSSELS
BE 0870.076.637
Ingelmunster · Eq €1,020,908
Dr. Jef Verheyen
BE 0849.190.656
Schilde · Eq €1,021,916
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 5,729 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-08-2001
Fiscal year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 24 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
4 entriesWebsite:users.telenet.be/koendepraeter/
E-mail:koen.de.praeter@telenet.be
Phone:093573582
Fax:093576559